OR WAIT null SECS
October 02, 2004
Big Pharma is ramping up capital spending in parenteral manufacturing at the same time that contract manufacturers are completing their own major investment programs.
September 02, 2004
Early development services continue to be a sweet spot for contract R&D services. The big question is how soon the impact of early-development candidates will be felt in late development and commercialization.
August 02, 2004
The contract services industry is fertile ground for the investment banking community this summer.
August 01, 2004
Data from the 2004 Outsourcing Survey indicate that pharmaceutical companies are spending more on outsourced drug development, but with fewer suppliers.
July 02, 2004
Despite investors' strong interest in the chemical industry overall, pharmaceutical chemical businesses have not experienced much attention from investors thus far.
June 02, 2004
It's not clear whether contract service providers can deliver the performance improvements and costs savings that drug companies expect from large, long-term, semi-exclusive contracts.
May 02, 2004
Sponsors who have been lax in performing financial due diligence on their contractors have been given a wake-up call by the recent developments at aaiPharma.
April 02, 2004
Recent events in the pharmaceutical outsourcing industry highlight the importance of ongoing attention to contractors' financial situations and their strategic intent.
March 02, 2004
As outsourcing services become a more integral part of pharmaceutical processes, drug companies are taking a harder line on consequential.
February 02, 2004
The changing fundamentals of the industry are causing Big Pharma to focus more on operating efficiency instead of just product performance.
